{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:15:07Z","timestamp":1783955707564,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["110-2320-B-006-047-MY3"],"award-info":[{"award-number":["110-2320-B-006-047-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012537","name":"Ditmanson Medical Foundation Chia-Yi Christian Hospital","doi-asserted-by":"publisher","award":["CYC109006"],"award-info":[{"award-number":["CYC109006"]}],"id":[{"id":"10.13039\/501100012537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.taap.2024.116888","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T12:06:19Z","timestamp":1709640379000},"page":"116888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells"],"prefix":"10.1016","volume":"485","author":[{"given":"I-Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chieh","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree Karani","family":"Kondapuram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ying","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohane Selvaraj","family":"Coumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Hei Antonio","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.taap.2024.116888_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10495-018-1507-2","article-title":"NF-\u03baB contributes to Smac mimetic-conferred protection from tunicamycin-induced apoptosis","volume":"24","author":"Abhari","year":"2019","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.taap.2024.116888_bb0010","article-title":"P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease","volume":"8","author":"Ahmed","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acs.chemrestox.9b00335","article-title":"Use of zebrafish in drug discovery toxicology","volume":"33","author":"Cassar","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2024.116888_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115080","article-title":"The SMAC mimetic LCL161 is a direct ABCB1\/MDR1-ATPase activity modulator and BIRC5\/Survivin expression down-regulator in cancer cells","volume":"401","author":"Chang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.116888_bb0025","article-title":"An updated review of Smac mimetics, LCL161, Birinapant, and GDC-0152 in cancer treatment","volume":"11","author":"Chang","year":"2021","journal-title":"Appl. Sci."},{"issue":"5","key":"10.1016\/j.taap.2024.116888_bb0035","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191388","article-title":"Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes","volume":"217","author":"Chen","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bph.12935","article-title":"YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells","volume":"172","author":"Cheng","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2024.116888_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105474","article-title":"YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair","volume":"166","author":"Cheng","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2024.116888_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-8-43","article-title":"Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers","volume":"8","author":"Cheung","year":"2009","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.taap.2024.116888_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023485","article-title":"BPR1K653, a novel Aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant Cancer cells","volume":"6","author":"Cheung","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12929-020-0627-5","article-title":"Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE","volume":"27","author":"Cheung","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"9","key":"10.1016\/j.taap.2024.116888_bb0065","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1021\/jm300060k","article-title":"Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)","volume":"55","author":"Flygare","year":"2012","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.taap.2024.116888_bb0070","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12033-021-00313-y","article-title":"Efficient stable cell line generation of Survivin as an in vitro model for specific functional analysis in apoptosis and drug screening","volume":"63","author":"Houshdarpour","year":"2021","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.taap.2024.116888_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00902","article-title":"HDAC2 and HDAC5 up-regulations modulate Survivin and miR-125a-5p expressions and promote hormone therapy resistance in estrogen receptor positive breast Cancer cells","volume":"8","author":"Huang","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08820130500496746","article-title":"Verapamil induces upregulation of P-glycoprotein expression on human monocyte derived dendritic cells","volume":"35","author":"Ishri","year":"2006","journal-title":"Immunol. Investig."},{"issue":"12","key":"10.1016\/j.taap.2024.116888_bb0085","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1124\/dmd.111.040733","article-title":"Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 Monobromide, novel small-molecule Survivin suppressant, with P-glycoprotein","volume":"39","author":"Iwai","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1158\/1535-7163.MCT-06-0482","article-title":"D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation","volume":"6","author":"Juang","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"6378","key":"10.1016\/j.taap.2024.116888_bb0095","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1126\/science.aar7389","article-title":"Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation","volume":"359","author":"Kim","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.taap.2024.116888_bb0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1873-3468.14018","article-title":"ABCB1\/MDR1\/P-gp employs an ATP-dependent twist-and-squeeze mechanism to export hydrophobic drugs","volume":"595","author":"Kodan","year":"2021","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.taap.2024.116888_bb0105","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1158\/1535-7163.MCT-12-0167","article-title":"YM155 reverses cisplatin resistance in head and neck Cancer by decreasing cytoplasmic Survivin levels","volume":"11","author":"Kumar","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"749","key":"10.1016\/j.taap.2024.116888_bb0110","doi-asserted-by":"crossref","first-page":"eabn2707","DOI":"10.1126\/scisignal.abn2707","article-title":"The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells","volume":"15","author":"Kurimchak","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.taap.2024.116888_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.561936","article-title":"Clinical perspective of FDA approved drugs with P-glycoprotein inhibition activities for potential Cancer therapeutics","volume":"10","author":"Lai","year":"2020","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.taap.2024.116888_bb0120","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/s41418-020-0541-0","article-title":"Targeting triple-negative breast cancers with the Smac-mimetic birinapant","volume":"27","author":"Lalaoui","year":"2020","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0125","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1038\/s41598-019-49152-7","article-title":"A novel zebrafish model to emulate lung injury by folate deficiency-induced swim bladder defectiveness and protease\/antiprotease expression imbalance","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.taap.2024.116888_bb0130","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/onc.2012.133","article-title":"Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src\/nuclear EGFR cascade-activated DNA repair activity","volume":"32","author":"Lee","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.taap.2024.116888_bb0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"10.1016\/j.taap.2024.116888_bb0140","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4161\/cbt.9.9.11432","article-title":"MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity","volume":"9","author":"Leung","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"10","key":"10.1016\/j.taap.2024.116888_bb0145","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.7150\/jca.69236","article-title":"BIRC5 modulates PD-L1 expression and immune infiltration in lung adenocarcinoma","volume":"13","author":"Ma","year":"2022","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.taap.2024.116888_bb0150","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","article-title":"MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models","volume":"101","author":"Mahon","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.taap.2024.116888_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/B:BIRE.0000007693.33521.18","article-title":"Mitotracker green is a P-glycoprotein substrate","volume":"23","author":"Marques-Santos","year":"2003","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yexcr.2004.08.029","article-title":"Survivin interacts with Smac\/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis","volume":"302","author":"McNeish","year":"2005","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.taap.2024.116888_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10549-008-0164-5","article-title":"Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells","volume":"117","author":"Moriai","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.taap.2024.116888_bb0170","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2147\/DDDT.S427470","article-title":"Statistical analysis in clinical and experimental medical research: simplified guidance for authors and reviewers","volume":"17","author":"Panos","year":"2023","journal-title":"Drug Design Develop. Therapy"},{"issue":"16","key":"10.1016\/j.taap.2024.116888_bb0175","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/bloodadvances.2020003829","article-title":"Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis","volume":"5","author":"Pemmaraju","year":"2021","journal-title":"Blood Adv."},{"issue":"13","key":"10.1016\/j.taap.2024.116888_bb0180","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s42003-020-1015-0","article-title":"Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy","volume":"3","author":"Rebelo de Almeida","year":"2020","journal-title":"Commun. Biol."},{"issue":"389","key":"10.1016\/j.taap.2024.116888_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aab1624","article-title":"Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion","volume":"8","author":"Rivadeneira","year":"2015","journal-title":"Sci. Signal."},{"issue":"38","key":"10.1016\/j.taap.2024.116888_bb0195","doi-asserted-by":"crossref","first-page":"31947","DOI":"10.1039\/C5RA22927H","article-title":"Disruption of protein\u2013protein interactions: hot spot detection, structure-based virtual screening and in vitro testing for the anti-cancer drug target \u2013 survivin","volume":"6","author":"Sarvagalla","year":"2016","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.taap.2024.116888_bb0200","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1016\/S0021-9258(17)41923-5","article-title":"ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells","volume":"269","author":"Shapiro","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0205","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1186\/s12885-019-6103-5","article-title":"Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice","volume":"19","author":"Shekhar","year":"2019","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.taap.2024.116888_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mam.2010.03.002","article-title":"VDAC, a multi-functional mitochondrial protein regulating cell life and death","volume":"31","author":"Shoshan-Barmatz","year":"2010","journal-title":"Mol. Asp. Med."},{"issue":"3","key":"10.1016\/j.taap.2024.116888_bb0215","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s13402-021-00595-z","article-title":"YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin","volume":"44","author":"Sun","year":"2021","journal-title":"Cell. Oncol."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/febs.12577","article-title":"Up-regulation of survivin by AKT and hypoxia-inducible factor 1\u03b1 contributes to cisplatin resistance in gastric cancer","volume":"281","author":"Sun","year":"2014","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0225","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1038\/s41598-017-08062-2","article-title":"Targeting P-glycoprotein: investigation of piperine analogs for overcoming drug resistance in cancer","volume":"7","author":"Syed","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.taap.2024.116888_bb0230","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.3892\/ol.2017.6597","article-title":"Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells","volume":"14","author":"Taglieri","year":"2017","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.taap.2024.116888_bb0235","doi-asserted-by":"crossref","first-page":"e2325","DOI":"10.1038\/cddis.2016.214","article-title":"Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152","volume":"7","author":"Tchoghandjian","year":"2016","journal-title":"Cell Death Dis."},{"issue":"21","key":"10.1016\/j.taap.2024.116888_bb0240","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.247379","article-title":"Mitochondrial survivin reduces oxidative phosphorylation in cancer cells by inhibiting mitophagy","volume":"133","author":"Townley","year":"2020","journal-title":"J. Cell Sci."},{"issue":"12","key":"10.1016\/j.taap.2024.116888_bb0245","doi-asserted-by":"crossref","first-page":"1900105","DOI":"10.1002\/adtp.201900105","article-title":"Identification of two novel small compounds that inhibit liver Cancer formation in zebrafish and analysis of their conjugation to Nanodiamonds to further reduce toxicity","volume":"2","author":"Tseng","year":"2019","journal-title":"Adv. Therap."},{"issue":"20","key":"10.1016\/j.taap.2024.116888_bb0250","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1093\/bioinformatics\/btz213","article-title":"PgpRules: a decision tree based prediction server for P-glycoprotein substrates and inhibitors","volume":"35","author":"Wang","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-016-0435-7","article-title":"LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC","volume":"35","author":"Yang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0260","doi-asserted-by":"crossref","first-page":"10791","DOI":"10.1038\/s41598-021-89931-9","article-title":"The inhibition of ABCB1\/MDR1 or ABCG2\/BCRP enables doxorubicin to eliminate liver cancer stem cells","volume":"11","author":"Yin","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.taap.2024.116888_bb0265","first-page":"608","article-title":"Characterization of a newly established human bladder carcinoma cell line, NTUB1","volume":"91","author":"Yu","year":"1992","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.taap.2024.116888_bb0270","doi-asserted-by":"crossref","first-page":"2390078","DOI":"10.1155\/2022\/2390078","article-title":"SBP-0636457, a novel Smac mimetic, cooperates with doxorubicin to induce necroptosis in breast Cancer cells during apoptosis blockage","volume":"2022","author":"Yu","year":"2022","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.taap.2024.116888_bb0275","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13046-020-01751-3","article-title":"OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.taap.2024.116888_bb0280","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/jcmm.13485","article-title":"LysoTracker and MitoTracker red are transport substrates of P-glycoprotein: implications for anticancer drug design evading multidrug resistance","volume":"22","author":"Zhitomirsky","year":"2018","journal-title":"J. Cell. Mol. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:03:46Z","timestamp":1758575026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":56,"alternative-id":["S0041008X24000863"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.116888","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.116888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116888"}}